Cambridge, United Kingdom

Rebekah Elisabeth Beevers


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rebekah Elisabeth Beevers: Pioneering Innovations in Allergy Treatment

Introduction

Rebekah Elisabeth Beevers is an accomplished inventor based in Cambridge, GB, recognized for her significant contributions in the field of therapeutic compounds. With a focus on allergy treatment, her innovative approach addresses the challenges posed by dust mite allergens, a common trigger for various allergic conditions.

Latest Patents

Beevers holds a patent titled "Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use." This invention revolves around specific pyruvamide compounds that inhibit dust mite Group 1 peptidase allergens, including Der p 1 and Der f 1. The patent outlines the therapeutic potential of these compounds and their pharmaceutical compositions, which can be utilized both in vitro and in vivo to treat diseases mediated by dust mite allergens. Conditions such as asthma, rhinitis, allergic conjunctivitis, and atopic dermatitis can benefit from the inhibition of these allergens, demonstrating the far-reaching impact of her work.

Career Highlights

Throughout her career, Beevers has collaborated with esteemed institutions such as St George's Hospital Medical School and The University of Manchester. Her academic endeavors and research have significantly contributed to the understanding and treatment of allergy-related disorders.

Collaborations

In her journey as an inventor, Rebekah Beevers has worked alongside notable colleagues, including Clive Robinson and Jihui Zhang. Their joint efforts have enriched her research contributions and played a crucial role in advancing the development of her patented inventions.

Conclusion

Rebekah Elisabeth Beevers exemplifies innovation within the scientific community, particularly in allergy treatment research. Her patented pyruvamide compounds provide a promising avenue for mitigating the effects of dust mite allergens, marking a notable achievement in her career. As a trailblazer in her field, Beevers continues to advance the frontiers of therapeutic solutions for allergy sufferers globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…